News from cytosorbents corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

Jan 23, 2015, 07:00 ET
CytoSorbents Logo.

CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal...

Jan 14, 2015, 09:00 ET
CytoSorbents Logo.

CytoSorbents Announces Closing of Public Offering

CytoSorbents Corporation (NASDAQ: CTSO) today announced the closing of a $10.3 million underwritten public offering of 1,250,000 shares of common...

Jan 07, 2015, 09:00 ET
CytoSorbents Logo.

CytoSorbents To Present at OneMedForum 2015 and Exhibit at the 44th Society of Critical Care Medicine Congress

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 30, 2014, 07:15 ET
CytoSorbents Logo.

CytoSorbents Submits IDE Application to FDA for U.S. CytoSorb® Cardiac Surgery Trial

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 23, 2014, 07:00 ET
CytoSorbents Logo

CytoSorbents Corporation Begins NASDAQ Trading Today

 CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 22, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development

 CytoSorbents Corporation (OTCQB:CTSOD), a critical care focused immunotherapy company marketing its CytoSorb® blood purification...

Dec 18, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Receives NASDAQ Listing Approval

 CytoSorbents Corporation (OTCQB: CTSOD), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine...

Dec 17, 2014, 11:34 ET

CytoSorbents kündigt strategische Partnerschaft mit Fresenius Medical Care an

 CytoSorbents Corporation (OTCQB: CTSOD), ein führendes Unternehmen auf den Gebieten Immuntherapie und Blutreinigung in der...

Dec 16, 2014, 21:55 ET

CytoSorbents conclut un partenariat stratégique avec Fresenius Medical Care

 CytoSorbents Corporation (OTCQB: CTSOD), leader dans le domaine de l'immunothérapie pour soins intensifs et de la purification du sang,...

Dec 16, 2014, 11:35 ET

CytoSorbents kondigt strategische samenwerking aan met Fresenius Medical Care

 CytoSorbents Corporation (OTCQB: CTSOD), een leider op het gebied van acute immunotherapie en bloedzuivering, kondigde gisteren een...

Dec 15, 2014, 11:15 ET
CytoSorbents Logo.

CytoSorbents Announces Strategic Partnership with Fresenius Medical Care

 CytoSorbents Corporation (OTCQB: CTSOD), a leader in critical care immunotherapy and blood purification, announced today that they have...

Dec 10, 2014, 09:25 ET
CytoSorbents Logo

Recent CytoSorb® Case Reports Highlight its Use to Help Save the Lives of Critically-Ill Patients

CytoSorbents Corporation (OTCQB: CTSO) trading under stock ticker symbol CTSOD, a critical care immunotherapy company commercializing its...

Dec 10, 2014, 09:10 ET
CytoSorbents Logo

Recent CytoSorb® Case Reports Highlight its Use to Help Save the Lives of Critically-Ill Patients

 CytoSorbents Corporation (OTCQB: CTSOD), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Dec 05, 2014, 20:00 ET
CytoSorbents Logo.

CytoSorbents Reports Temporary Change of Stock Trading Symbol

CytoSorbents Corporation (OTCQB: CTSOD; OTCQB: CTSO), a critical care immunotherapy company specializing in blood purification to treat...

Dec 05, 2014, 15:37 ET
CytoSorbents Logo.

CytoSorbents Teams with Smart Medical Solutions to Distribute CytoSorb® in Romania and Moldova

 CytoSorbents Corporation (OTCQB: CTSO) (OTCQB: CTSOD), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal...

Nov 26, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents to Host Second CytoSorb® Users Meeting and Symposium at the DIVI Critical Care Congress

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy  company commercializing its CytoSorb® cytokine adsorber to...

Nov 21, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents Wins Beacon of Light Award

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb®...

Nov 14, 2014, 09:00 ET
CytoSorbents Logo.

CytoSorbents Announces Appointment of New Board Director

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Nov 12, 2014, 16:14 ET
CytoSorbents Logo.

CytoSorbents Achieves First $1M in Quarterly CytoSorb Sales in Q3 2014

 CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber to treat...

Nov 10, 2014, 07:00 ET
CytoSorbents Logo.

CytoSorbents Announces Initial Partnership with a Leading Global Cardiac Surgery Company

 CytoSorbents Corporation (OTCQB: CTSO), a blood purification company commercializing its CE Mark approved CytoSorb® extracorporeal...